Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New research suggests a biomimetic hematoma scaffold may regenerate large bone defects using a fraction of the rhBMP-2 dose currently used in clinical practice.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard bone repair methods. Learn what the study found.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard collagen sponge delivery in large bone defect repair.
By Peptide Association Research Team